Phazyme
FDA Label NDC 0132-0214

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by C.b. Fleet Company, Inc. for the product Phazyme (NDC 0132-0214). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, use, stop use and ask a doctor if, directions, other information, inactive ingredients, questions?, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient

(in each softgel)

Simethicone 250mg

Purpose

Anti-gas

Use

relieves bloating, pressure or fullness commonly referred to as gas

Stop Use And Ask A Doctor If

Stop use and ask a doctor if condition persists

Directions

  • swallow one or two softgels after a meal
  • do not exceed two softgels per 24 hours except under the advice and supervision of a physician

Other Information

  • store at room temperature 59° - 86°F (15° - 30°C)

Inactive Ingredients

Red No. 33, FD&C Blue No. 1, Purified Water, Gelatin, Glycerin, Titanium Dioxice

Questions?

Call toll-free 1-855-727-4277

Package Label.Principal Display Panel

Phazyme 250 mg 24 Ct Carton (Phazyme250mg24ctcarton)

Phazyme 250 mg 24 Ct Carton (Phazyme250mg24ctcarton)

Phazyme 250 mg 24 Ct Carton (Phazyme250mg24ctcarton)

Phazyme 250 mg 24 Ct Carton (Phazyme250mg24ctcarton)

* Please review the disclaimer below.